# Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026

- Source: PR Newswire M&A
- Published: 2026-11-04T13:35:00+00:00
- Category: Local
- Original: https://www.prnewswire.com/news-releases/anixa-biosciences-announces-presentation-of-ovarian-cancer-car-t-clinical-trial-at-esmo-immuno-oncology--advanced-therapies-congress-2026-302928923.html
- Canonical: https://groundlevelnews.com/story/anixa-biosciences-announces-presentation-of-ovarian-cancer-car-t-clini-c0d4e3/

Dr. Robert Wenham, principal investigator of Anixa's Phase 1 clinical trial at Moffitt Cancer Center, to present on December 14 in London SAN JOSE, Calif., Nov. 4, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._